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Abstract
Previous data show a relation between GSH content and proliferation of normal and tumour cells. We recently
demonstrated a specific involvement of GSH in the autophosphorylation activity of the platelet-derived growth factor
(PDGF) receptor in NIH3T3 fibroblasts. In this study we demonstrate that the stimulation by PDGF of serum-starved
NIH3T3 cells increases cellular GSH content, while no change in oxidized GSH content was measured. Experiments
performed with actinomycin, cycloheximide and buthionine sulfoximide, a specific inhibitor of the rate-limiting enzyme of
the de novo synthesis of GSH Q-glutamylcysteine synthetase (Q-GCS), confirm PDGF induction of GSH synthesis. These
results provide the first demonstration that PDGF mediated transduction signals seem strictly related to mechanisms
involved in the increase of Q-GCS activity associated with increased Q-GCS heavy subunit mRNA levels. In fact, serum and
epidermal growth factor (EGF) stimulation of quiescent NIH3T3 and NIH3T3, which overexpress EGF receptor, does not
affect GSH content or its synthesis. These data may be related to a possible GSH role in the redox regulation of cell
proliferation mediated by PDGF. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
GSH, a ubiquitous cellular non-protein sulfhydryl,
is involved in many cellular functions, including de-
toxi¢cation mechanisms [1], the maintenance of the
intracellular redox status [2] and the regulation of the
activity of some enzymatic and transport proteins
[3^6]. Moreover, it has been shown that GSH regu-
lates DNA synthesis [7] and that GSH cellular levels
can in£uence cell growth [7^9]. Previous studies have
reported that GSH increases are associated with mi-
togenic stimulation in NIH3T3 ¢broblasts [8] and
that GSH may support the proliferation of rabbit
lymphocytes stimulated by mitogens [10]. Tereadez
et al. show that GSH controls the onset of tumour
cell proliferation by regulating protein kinase C ac-
tivity and intracellular pH [11]. Our previous data
demonstrate that GSH synthesis is selectively en-
hanced in NIH3T3 ¢broblasts transformed by specif-
ic oncogenes involved in mitogenic signal transduc-
tion and associated with radio and pharmaco-
resistance [12].
There is also some evidence to indicate that cellu-
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lar transformation is accompanied by an increase in
GSH content, and that changes in the rate of cancer
cell proliferation are related to changes in their intra-
cellular GSH levels [11,13,14]. These changes are
often due to an increased expression of Q-glutamyl-
cysteine synthetase (Q-GCS) [15^17], the rate-limiting
enzyme of the de novo synthesis of GSH [15]. Cell
treatment with L-buthionine sulfoximine (BSO), a
speci¢c inhibitor of Q-GCS [18], results in an antipro-
liferative e¡ect and a major sensitivity to anti-cancer
therapy [11,15,19^21]. Recently, a redox regulation
of signal transduction which may involve GSH has
been suggested [10,22,23]. In fact, GSH and GSSG
by thiol/disul¢de exchange reactions may in£uence
both the redox status and the reactivity of speci¢c
thiol groups of redox-sensitive enzymes [3,4], includ-
ing protein tyrosine kinase and phosphatases
[22,24,25].
It would therefore seem that the activity of these
enzymes as well as of transcriptional factors involved
in cell-cycle progression is related to both redox reg-
ulation and GSH levels [26]. The possible early in-
volvement of GSH in the mitogenic signal cascade is
also supported by ¢ndings obtained in vitro, which
show a GSH-dependent alteration of kinase activity
in both isolated insulin and epidermal growth factor
(EGF) receptors [27]. We have demonstrated that in
NIH3T3 ¢broblasts a speci¢c critical intracellular
GSH level is necessary for maximal autophospho-
rylation and the activation of the platelet-derived
growth factor (PDGF) receptor [28]. Recently, vari-
ous authors have demonstrated a transient produc-
tion of H2O2 and reactive oxygen species (ROS) in
mammalian cells stimulated with di¡erent ligands,
including cytokines and growth factors, and they
have prospected these ROS as second messengers
[23,29]. Inhibition of this increase in intracellular
ROS has been shown to inhibit PDGF-stimulated
signal transduction [24]. The exact molecular tar-
get(s) of oxidants for the induction of signal trans-
duction have yet to be clari¢ed. It is interesting that
ROS induce expression of the human Q-GCS gene by
activation of transcriptional factors that bind the
oligonucleotide consensus region of the Q-GCS pro-
moter [30^33]. Considering these previous results and
that little is known about a possible direct relation-
ship between GSH and the regulation of cell growth
in vivo, we studied the e¡ect of PDGF-mediated mi-
togenic stimulation on GSH intracellular content and
its endogenous synthesis in NIH3T3 ¢broblasts
which are particularly rich in PDGF receptors [28].
2. Materials and methods
2.1. Cell culture and stimulation
NIH3T3 murine ¢broblasts were obtained from
the Istituto Nazionale Tumori (Milan, Italy);
NIH3T3-overexpressing EGF-receptor (NIH3T3/
EGFr) from the Laboratory of Cellular and Molec-
ular Biology of the National Cancer Institute (NIH,
Bethesda, MD, USA). The cells were routinely cul-
tured at low density in a humidi¢ed atmosphere of
5% CO2 at 37‡C in Dulbecco’s modi¢ed Eagle’s me-
dium without sodium pyruvate supplemented with
10% (v/v) foetal calf serum (FCS). Subcon£uent cells
were starved for 24 h in a medium containing 0.5%
FCS. Fibroblasts were then cultured in fresh medium
and stimulated with 10% FCS or 20 ng/ml PDGF-BB
(from Peprotech) or 100 ng/ml EGF for various pe-
riods of time. Receptor stimulation and tyrosine
phosphorylation was checked by Western blot anal-
ysis using antibodies speci¢c either to receptors or to
phosphotyrosine [28].
2.2. Cell treatments
In order to deplete cytosol GSH content, 0.2 mM
diethylmaleate (DEM) was added to a medium of 24
h-starved cells; after 20 min the cells were washed
twice with ice-cold PBS at pH 7.4 and fresh medium
was added, along with 10% FCS or 20 ng/ml PDGF,
as previously described. In some experiments DEM-
treated cells stimulated or not for 3 h, were incubated
with 0.5 mM BSO added to culture medium for fur-
ther 3 h, to inhibit Q-GCS activity. Other experiments
were performed in presence of actinomycin D and
cycloheximide. Fresh medium containing or not ei-
ther 0.2 Wg/ml actinomycin D or 1.5 Wg/ml cyclohex-
imide was added to 24 h-starved cells stimulated with
10% FCS or 20 ng/ml PDGF for a further 24 h.
2.3. Determination of cellular GSH and GSSG levels
The cells (V1U106) were washed and, after tryp-
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sin treatment, were counted and centrifuged at
125Ug for 10 min. The precipitate was washed again
and directly dissolved in 0.2 ml 5% aqueous HClO4
to measure GSH, glutamic acid and cysteine by the
HPLC method, as described by Reed and Fariss [34].
Brie£y, perchloric extract was added with 50 Wl of
1 mM Q-glutamylglutamate (internal standard) and
sonicated three times for 5 s. The proteins were pre-
cipitated by centrifugation in a microcentrifuge at
12 550Ug for 10 min. The supernatant was neutral-
ized by K2CO3. Then 20 Wl of 300 mM iodoacetic
acid and 100 Wl of 0.7 M NaHCO3 were added to 0.2
ml of extract. The resulting alkaline solution was
incubated for 1h at room temperature in complete
darkness. 0.1 ml of 5% (v/v) £uorodinitrobenzene
dissolved in ethanol was added to the supernatant,
which was then stored at room temperature over-
night. The solution was analyzed by liquid chroma-
tography (Beckman Gold System equipped with an
NEC/PC 8201 H computer, a Shimadzu C-R6A
chromatopac integrator, and Biosil NH290-5S Bio-
Rad column). The 2,4-dinitrophenyl derivatives
were detected at 365 nm. The metabolites were quan-
ti¢ed relative to internal standard by integration. All
samples were assayed in triplicate, and results are
expressed as nmol of GSH/106 cells.
2.4. Q-GCS enzyme activity assay
24 h-starved cells were stimulated with 10% FCS
or growth factors for a further 3, 6, 13 and 24 h, and
then treated with 0.2 mM DEM for 20 min to de-
plete cytosol GSH content and to minimize feedback
inhibition of GSH on Q-GCS. The cells (V10U106)
were washed, collected by scraper and centrifuged at
125Ug for 10 min. The precipitate was resuspended
using 0.5 ml 150 mM Tris bu¡er containing 5 mM
MgCl2, 2 mM 1,4-dithiothreitol at pH 7.5. The cells
were lysed by sonication at 4‡C. The homogenate
was centrifuged at 12 550Ug for 30 min. The super-
natant was assayed for Q-GCS activity by continuous
optical test using Seelig’s method [35]. Enzymatic
activity was expressed in terms of Wmol/min per mg
of total protein.
2.5. Analysis of Q-GCS-HS mRNA
After 24 h of starvation cells (4^10U106) were
stimulated with serum or growth factors as previ-
ously described. At di¡erent times of stimulation,
total RNA was isolated from the cells by the guani-
dinium thiocyanate/phenol/chloroform method [36].
Total RNA was quanti¢ed spectrophotometrically,
treated with formaldehyde and subjected to electro-
phoresis in denaturing 1.2% (w/v) agarose gel.
Northern blot analysis was performed by standard
method and probed by a full-length 2.1 kb mouse
heavy-chain Q-GCS clone. cDNA coding from Q-
GCS-HS was generously provided by Kang [37].
The probes were 32P-labelled using a random pri-
ming kit from Promega, according to manufacturer’s
instructions. The separated RNAs were transferred
to Hybond N nylon membrane (Amersham), pre-
hybridized in PHS (10 mM phosphate, 5UDen-
hardt’s solution, 6USSCs, 1 mM EDTA and 5%
(w/v) dextran sulfate) for 4 h, and then hybridized
for 16 h in the same solution using a speci¢c probe,
32P-labelled (106 cpm/ml), at 65‡C. Washes were per-
formed two times in 0.5USSCs and 0.1% (w/v) SDS,
at 50‡C. The ¢lters were subjected to autoradiogra-
phy at 380‡C using Kodak ¢lm and intensifying
screens for an appropriate time. Blots were stripped
and re-probed with a labelled actin cDNA probe to
normalize for the amount of mRNA loaded per lane.
The ¢lms were scanned and densitometric analysis
was performed to quantify the speci¢c hybridization.
2.6. Protein determination
Protein concentration was determined by the
Bradford method [38]. Bovine serum albumin (Sigma
Chemical Co., St. Louis, MO, USA) was used as
standard.
2.7. Statistical analyses
Statistical analyses were evaluated using Student’s
t-test. P9 0.05 was considered signi¢cant.
3. Results
3.1. E¡ect of PDGF stimulation on the cellular
GSH redox system
NIH3T3 cells were serum starved for 24 h and
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then stimulated with either FCS or PDGF added to
the basal medium. GSH and GSSG content were
measured at various times after the stimulations. Ta-
ble 1 reports the di¡erent components of the GSH
system, and shows that signi¢cant increases in GSH,
total GSH equivalents (GSH+2GSSG) and GSH/
GSSG ratio were found only after PDGF stimulation
as compared with 24 h starved cells (control). No
variation was observed after FCS stimulation at
studied times. Most notably, total GSH content in-
creased after 6, 16 and 24 h from PDGF stimulation,
by about 44%, 66% and 130%, respectively, as com-
pared with control. The statistically signi¢cant in-
creases obtained in the GSH/GSSG ratio was due
to the changes in GSH content, considering that no
signi¢cant variation of GSSG content was measured
at studied time. No change in GSH and GSSG con-
tents was measured during the ¢rst 3 h from PDGF
stimulation (data not shown). Considering that in all
experiments performed, the PDGF e¡ect was ob-
served in GSH content and not in GSSG, we have
reported subsequently only the values of total GSH
indicated as GSH. The e¡ect of various concentra-
tions of PDGF on cellular GSH was examined after
24 h of incubation. Fig. 1 shows GSH increases re-
lated to PDGF concentration.
3.2. E¡ect of PDGF stimulation on GSH depleted
cells by pretreatment with diethylmaleate
DEM has been widely used in vivo and in tissue
culture to deplete intracellular GSH [26]. In fact, a
chemical reaction between DEM and GSH forms a
complex that is then metabolized. GSH depletion
occurred in starved NIH3T3 quickly after 20 min
of DEM treatment. These DEM-treated cells (con-
trol) were stimulated or not using either serum or
PDGF. Fig. 2 shows a statistically signi¢cant in-
crease of GSH content after 6 h, both in stimulated
and non-stimulated cells with respect to control.
However, GSH content reached a very high value
after PDGF stimulation, with an enhancement of
about 130%, as compared with values measured after
6 h in both serum-stimulated and non-stimulated
cells. This GSH increase was similar to that obtained
Table 1
Levels of GSH system components in serum and PDGF-stimulated NIH3T3 cells after di¡erent times from the stimulation
Starved cells Stimulation time (h)
6 16 24
FCS PDGF FCS PDGF FCS PDGF
GSH 3.00 þ 0.34 3.00 þ 0.30 4.50 þ 0.60** 3.50 þ 0.30 5.50 þ 0.33** 3.60 þ 0.45 7.50 þ 0.60**
GSSG 0.30 þ 0.04 0.22 þ 0.04 0.34 þ 0.05 0.25 þ 0.04 0.30 þ 0.03 0.30 þ 0.03 0.40 þ 0.04
Total GSH 3.60 þ 0.30 3.70 þ 0.44 5.20 þ 0.50* 4.00 þ 0.40 6.00 þ 0.20** 4.20 þ 0.50 8.30 þ 0.60**
GSH/GSSG 10.0 þ 1.70 13.6 þ 2.00 13.2 þ 0.20 14.0 þ 1.70 21.0 þ 0.60** 12.0 þ 1.00 19.0 þ 1.00**
24 h-starved cells were stimulated with 20 ng/ml PDGF or 10% serum. GSH and GSSG were measured by HPLC method [34] as de-
scribed in Section 2 and are expressed as nmol/106 cells. Total GSH = ([GSH]+2[GSSG]). Data are mean þ S.E.M. of four experiments
each performed on duplicate samples.
*P9 0.05, **P9 0.005, compared to starved cells.
Fig. 1. GSH content in starved NIH3T3 cells following stimula-
tion with di¡erent PDGF concentrations. 24 h-starved cells
were stimulated with di¡erent PDGF concentrations for 24 h.
Data are expressed as GSH content % of starved cells and are
mean þ S.E.M. of four experiments. GSH content in starved
cells : 3.6 þ 0.3 nmol/106 cells. *P9 0.05, **P9 0.001, compared
to starved cells.
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in non-DEM treated cells after 24 h from PDGF
stimulation (Table 1). To verify if this PDGF e¡ect
was due to the induction of GSH synthesis, a speci¢c
inhibitor of GSH endogenous synthesis, BSO, was
used. DEM-treated cells stimulated or not either
with serum or PDGF for 3 h, were incubated with
BSO, added to the culture medium, for a further 3 h
(Fig. 2).
In all cells thus treated, GSH content did not in-
crease; on the contrary it decreased, indicating that
both the GSH elevation measured after GSH deple-
tion in serum-stimulated and non-stimulated cells, as
well as that observed in PDGF-stimulated cells were
due to GSH biosynthesis. Similar results were ob-
tained in non-DEM treated cells stimulated with
PDGF when BSO was added to culture medium
after 16 h from the stimulation; no GSH increase
was measured after 24 h from the PDGF stimulation
in presence of BSO (data not shown).
3.3. E¡ect of PDGF stimulation on GSH synthesis
Considering the results obtained by DEM and
BSO experiments, we veri¢ed if GSH increase follow-
ing PDGF stimulation was e¡ectively due to activa-
tion of GSH biosynthesis. Initially we determined the
involvement of de novo synthesis of protein or RNA
Fig. 2. E¡ect of PDGF stimulation on GSH content in DEM-
treated NIH3T3 cells. 24 h-starved cells were GSH depleted by
treatment with 0.2 mM diethylmaleate (DEM) for 20 min. Sub-
sequently DEM-treated cells (control) were washed twice with
PBS, and medium culture was added to the cells. DEM-treated
cells were non-stimulated (black bars), or stimulated with 10%
FCS (dotted bars) or 20 ng/ml PDGF (white bars) for 3 h and
6 h at 37‡C. In some experiments DEM-treated cells, stimulated
or not for 3 h, were incubated with 0.5 mM BSO for further
3 h; 6 (+BSO). Data are expressed as GSH content % of con-
trol and are mean þ S.E.M. of three experiments. GSH content
in control: 1.3 þ 0.2 nmol/106 cells. (Basal GSH content in not
depleted cells : 3 þ 0.34 nmol/106 cells.) *P9 0.05, **P9 0.005,
compared to control. ‡P9 0.05; ‡‡P90.001, compared to values
measured after 6 h in cells without BSO.
Fig. 3. Q-GCS speci¢c activity in cell-free extracts of NIH3T3
cells after di¡erent time from PDGF stimulation. 24 h-starved
cells, stimulated with 20 ng/ml PDGF, were treated with 0.2
mM DEM for 20 min to eliminate intracellular GSH and to
minimize feedback inhibition by GSH. Q-GCS activity was
measured in cytosolic fractions by Seelig’s method [35] and ex-
pressed as Wmol/min per mg protein. Data are mean þ S.E.M.
of three experiments. *P9 0.05, compared to starved cells.
Table 2
E¡ect of actinomycin D and cycloheximide on GSH content in
FCS- or PDGF-stimulated NIH3T3 cells
Treatment GSH content (nmol/106 cells)
FCS PDGF
None (control) 3.6 þ 0.45 8.00 þ 0.60
Actinomycin D 3.0 þ 0.35 4.00 þ 0.20*
Cycloheximide 3.6 þ 0.20 3.30 þ 0.17*
0.2 Wg/ml actinomycin D or 1.5 Wg/ml cycloheximide were
added to 24 h-starved cells stimulated with 10% FCS or 20 ng/
ml PDGF for a further 24 h. Data are mean þ S.E.M. of three
experiments.
*P9 0.005 compared to control.
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in serum or PDGF stimulated cells incubated or not
with either cycloheximide or actinomycin D for 24 h.
As seen in Table 2, both compounds decreased GSH
content by about 50% and 60% in PDGF-stimulated
cells, as compared with control, while no GSH de-
crease was measured in serum-stimulated cells. We
then determined the PDGF e¡ect on the catalytic
activity of the regulatory and rate-limiting enzyme,
Q-GCS, in cell-free extracts prepared from starved
NIH3T3 cells stimulated or not with PDGF or serum
for di¡erent times. The highest activity of Q-GCS in
PDGF stimulated cells was measured after 6 h of
incubation and a signi¢cant increase of about 50%,
as compared with starved cells, was determined (Fig.
3). No change of Q-GCS activity in serum-stimulated
cells at studied times was determined (data not
shown). In view of these results, we investigated the
mechanism accounting for the up-regulation of cel-
lular GSH levels. The e¡ect of PDGF on the level of
the Q-GCS heavy subunity (Q-GCS-HS) mRNA was
determined. In fact, Q-GCS is composed of two sub-
units, one heavy and one light chain (Q-GCS-LS),
Fig. 4. Q-GCS-HS mRNA levels after di¡erent times from the PDGF or FCS stimulation of starved NIH3T3 cells. (A) Northern blot
analysis. Total RNA were extracted from 24 h-starved cells stimulated with 20 ng/ml PDGF or 10% FCS. The extracts were frac-
tionated on a formaldehyde agarose gel, transferred to charged nylon membranes and hybridized with radiolabeled probes speci¢c for
Q-GCS-HS mRNA and L-actin as described in Section 2. (B) Densitometric analysis. Q-GCS-HS mRNA levels after PDGF stimulation
(white bars) or FCS stimulation (black bars) were compared with L-actin bands used as quantitative control. Values were expressed as
relative to starved cells þ S.E.M. of four di¡erent preparations.
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and the catalytic activity resides in the heavy subunit
[15]. Total cellular RNA was then extracted from
starved and PDGF or serum-stimulated cells after
di¡erent incubation times. Northern blot analysis
and densitometric quantitation (Fig. 4) showed a sig-
ni¢cant increase, of about 4-fold, of Q-GCS-HS
mRNA content after 3 h from PDGF stimulation
as compared with starved cells. The picture of
mRNA levels in serum-stimulated cells is di¡erent
from that observed in PDGF-stimulated cells, in
fact only after 16^24 h from serum stimulation was
an increase of about 1-fold measured with respect to
starved cells. These ¢ndings indicate that PDGF-
stimulated expression of Q-GCS correlates with the
increase of Q-GCS activity and GSH levels.
3.4. Speci¢city of PDGF-induced GSH increase
In order to verify the speci¢city of PDGF-induced
GSH increase, we compared the e¡ect on the GSH
content of serum or PDGF or EGF stimulation in
NIH3T3 serum-starved cells overexpressing EGF re-
ceptor, tyrosine kinase family receptor structurally
related to PDGF receptor. We used these cells, since
NIH3T3 cells contain low levels of EGF receptor as
compared with PDGF receptor [28]. The values
measured after 24 h from stimulation indicated that
GSH content did not change after EGF stimulation
(3.0 þ 0.30 nmol/106 cells) as compared with starved
(3.2 þ 0.32 nmol/106 cells) or FCS cells (3.2 þ 0.30
nmol/106 cells), while it increased of about 70% in
PDGF-stimulated cells (5.5 þ 0.40 nmol/106 cells).
No evident variation was determined at earlier times
after EGF stimulation; similarly, no evident change
was observed in Q-GCS-HS mRNA level (data not
shown).
4. Discussion
This work shows for the ¢rst time in vivo a speci¢c
relation between PDGF stimulation and induction of
GSH synthesis in NIH3T3 ¢broblasts. The analysis
of the data indicates time- and dose-PDGF-depen-
dent increase of GSH content and a strict relation
between the time-course behaviour of Q-GCS activity
and mRNA levels. Data reported in literature sug-
gest a role for GSH in normal and tumour cell pro-
liferation [7^11,13,14]. Shaw and Chou [8] showed
that mitogenic stimulation by serum of quiescent
Swiss 3T3 cells results in a rapid rise in cellular
GSH content (after about 1 h from the stimulation),
followed by a second more gradual increase as cells
initiate DNA synthesis. The authors therefore con-
clude that a relationship between cell proliferation
and an increase of GSH content exists. Our results
are only partly in agreement with these data, since a
GSH increase in NIH3T3 is obtained after PDGF
stimulation and not in serum-stimulated cells. More-
over, no marked elevation of GSH content is meas-
ured after 1 h from PDGF stimulation, a signi¢cant
increase being determined only after 6 h. These dif-
ferences may be due to the di¡erent experimental
conditions: for example, Shaw and Chou use a
very low-density culture of 3T3 cells and longer star-
vation times (72 h). Subsequently, other authors
found increases of GSH content after serum stimu-
lation of quiescent rat kidney ¢broblasts (NRK49F)
[39]. However, they demonstrated that these GSH
increases are not due to mitogenic stimulation, but
rather to the addition of fresh medium and thereafter
of a new supply of GSH precursors (cysteine and
glutamic acid). We exclude this possibility consider-
ing that no increase in GSH level is obtained by
serum stimulation followed by new medium addition.
Various factors could contribute to the PDGF-medi-
ated GSH increase, such as GSH-e¥ux inhibition,
reduced catabolism, activation of synthesis, break-
down of GSH mixed disul¢des with proteins and
reduction of GSSG. The last hypothesis seems un-
likely, considering that GSSG levels are very low and
that no change of GSSG content is detected after
PDGF stimulation at studied times (Table 1).
GSH-e¥ux inhibition is also excluded, since no
GSH content was measured in culture medium in
serum- or PDGF-stimulated cells (data not shown).
Sometimes increases of Q-glutamyltranspeptidase ac-
tivity have been implicated in increased GSH levels
[40], but this is not possible since this enzyme activity
in plasma membranes of NIH3T3 cells has not been
detected [28]. Finally, experiments performed with
actinomycin, cycloheximide and BSO in normal
and GSH-depleted cells show that PDGF stimulation
increases GSH content by activating its endogenous
synthesis. In e¡ect, even if the mechanisms involved
in the induction of GSH synthesis are still little
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known and complex, an increase of cellular GSH
levels is often related to an increase of Q-GCS activity
and to activation of Q-GCS expression, as is con-
¢rmed by this study.
An elevation of intracellular GSH associated with
cell proliferation is mainly related to the role of GSH
in the regulation of DNA synthesis, by in£uencing
nucleotide biosynthesis. However, our data show
that the induction of GSH synthesis in NIH3T3
seems strictly related to PDGF mediated transduc-
tion signals. In fact, the stimulation by EGF receptor
does not a¡ect GSH content, or Q-GCS expression
and serum-stimulated cells show an increase of
Q-GCS-HS mRNA levels, but it is smaller and occurs
later than that measured after PDGF stimulation
and it is not associated with increased levels of
GSH and Q-GCS activity. These data may be due
to the presence in the serum of di¡erent mitogenic
agents, and recently a di¡erent and not co-ordinated
regulation of the expression of Q-GCS-HS and
Q-GCS-HL has been found in cultured rat hepato-
cytes with hormones, such as insulin and hydrocor-
tisone [41]. E¡ectively di¡erent regulation mecha-
nisms may be involved in Q-GCS expression and
activity [42,43]. Many ¢ndings demonstrate that oxi-
dants and redox changes induce the expression of
antioxidant enzymes, including Q-GCS, by the activa-
tion of speci¢c transcriptional factors [23,24,30^33]
such as AP-1 and NF-KB, which are regulated
through alterations in their redox status [30,32,33]
and which may bind speci¢c sites in the 5P-regulatory
region of the Q-GCS heavy subunit gene. In e¡ect,
remarkable activation of GSH synthesis is obtained
in DEM-treated NIH3T3 cells after PDGF stimula-
tion (Fig. 2), and this may be due also to GSH de-
pletion and subsequent induction of oxidative stress
generated by DEM treatment [26] as also reported by
other authors [41]. These data suggest that the
PDGF induction of GSH synthesis could be medi-
ated via redox cycle generated by PDGF receptor
activation, since H2O2 and ROS seem to be media-
tors of PDGF mitogen activity [24]. This oxidative
status may explain the rapid increase in Q-GCS
mRNA content. It is also possible to hypothesize
that a GSH reducing system plays an important
physiological role in the restoration (i.e., reduction)
of target proteins oxidized by ROS, such as protein
tyrosine phosphatases (PTPs). Speci¢c and reversible
inactivation of PTPs by covalent modi¢cation of crit-
ical sulfhydryl residues due to H2O2 generated dur-
ing growth factor stimulation has been demonstrated
[25]. The reversibility of this process depends on the
redox status of the cell, the availability of reduced
thiols such as GSH, and reaction kinetics. Consider-
ing these data, the progressive increase of the GSH
content and GSH/GSSG ratio (Table 1) may contrib-
ute to the reversible inactivation of the cysteine sul-
fenic acid intermediate of PTPs and to the regulation
of the mitogenic signal of PDGF [24]. However, con-
sidering that an increase in intracellular levels of
ROS after EGF or other ligand stimulation has
also been demonstrated [44,45], and that no EGF-
induction of GSH synthesis in NIH3T3 cells has
been observed, the speci¢city of PDGF e¡ect on
GSH synthesis cannot be related only to ROS pro-
duction but also to other speci¢c factors involved in
the di¡erent mitogenic signalling pathways of various
growth factors. Recent studies on Swiss 3T3 ¢bro-
blasts have shown that PDGF but not EGF stimu-
lates sphingosine kinase activity, and that PDGF-
stimulated DNA synthesis is prevalently associated
to the formation of sphingosine-1-phosphate, which
stimulates DNA-binding of transcriptional factors
such as AP-1 [46]. Moreover, the accumulation of
GSH levels after 16^24 h from PDGF stimulation
may explain the decrease in both the activity and
the expression of Q-GCS by down- and up-regulation
mechanisms. Taking all these observations into ac-
count, we conclude that PDGF stimulation speci¢-
cally modulates GSH synthesis and its homeostasis.
Cellular GSH status seems to play an important role
at di¡erent levels of PDGF-mediated signal trans-
duction events, considering also our previous results,
which demonstrate a speci¢c relation in NIH3T3
cells between a critical level of GSH and the phos-
phorylation and mitogenic action of PDGF receptor
[28]. Further studies are needed to individualize spe-
ci¢c targets and reactions which may relate the di¡er-
ent components of the GSH system to the PDGF
signal pathway. Elucidation of the mechanisms in-
volved in the transcriptional regulation of Q-GCS
and in GSH homeostasis may be helpful in designing
strategies to control the cell proliferation of normal
and tumour cells.
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